Try our beta test site

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2016 by University of Pittsburgh
Sponsor:
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Leonard Appleman, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01550367
First received: February 29, 2012
Last updated: December 22, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)